Allmed Solutions Ltd (ALMD.TA)
ILA 32.7
(0.0%)
ILA 32.7
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.69 Million ILS | 14.35% |
| 2022 | -12.49 Million ILS | -344.16% |
| 2021 | -7.89 Million ILS | 199.17% |
| 2020 | -7.95 Million ILS | -121.46% |
| 2019 | 24.04 Million ILS | 232.12% |
| 2018 | -18.41 Million ILS | 11.61% |
| 2017 | -20.58 Million ILS | 4.77% |
| 2016 | -21.61 Million ILS | -20.09% |
| 2015 | -18 Million ILS | 13.95% |
| 2014 | -20.92 Million ILS | 35.08% |
| 2013 | -32.22 Million ILS | -31.33% |
| 2012 | -23.47 Million ILS | -107.25% |
| 2011 | -11.65 Million ILS | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2573.50 ILS | 69.82% |
| 2024 Q2 | -2573.50 ILS | 0.0% |
| 2023 FY | - ILS | 14.35% |
| 2023 Q4 | -8528.50 ILS | -0.32% |
| 2023 Q1 | 3260.50 ILS | 202.14% |
| 2023 Q2 | 3260.50 ILS | 0.0% |
| 2023 Q3 | -8501.33 ILS | -360.74% |
| 2022 Q4 | -3192.25 ILS | -0.99% |
| 2022 FY | - ILS | -344.16% |
| 2022 Q3 | -3160.83 ILS | -10.19% |
| 2022 Q2 | -2868.50 ILS | 0.0% |
| 2022 Q1 | -2868.50 ILS | -63.03% |
| 2021 Q1 | -1933.50 ILS | 53.18% |
| 2021 Q2 | -1933.50 ILS | 0.0% |
| 2021 Q4 | -1759.50 ILS | 6.98% |
| 2021 FY | - ILS | 199.17% |
| 2021 Q3 | -1891.50 ILS | 2.17% |
| 2020 Q4 | -4129.50 ILS | -2.67% |
| 2020 Q1 | -168.00 ILS | 96.05% |
| 2020 Q2 | -168.00 ILS | 0.0% |
| 2020 FY | - ILS | -121.46% |
| 2020 Q3 | -4022.17 ILS | -2294.15% |
| 2019 Q3 | -4280.50 ILS | -13.15% |
| 2019 Q4 | -4248.50 ILS | 0.75% |
| 2019 FY | - ILS | 232.12% |
| 2019 Q1 | -3783.00 ILS | 25.63% |
| 2019 Q2 | -3783.00 ILS | 0.0% |
| 2018 Q3 | -5132.50 ILS | 6.72% |
| 2018 FY | - ILS | 11.61% |
| 2018 Q2 | -5502.50 ILS | 0.0% |
| 2018 Q1 | -5502.50 ILS | -1.02% |
| 2018 Q4 | -5086.50 ILS | 0.9% |
| 2017 Q2 | -4966.50 ILS | 0.0% |
| 2017 Q3 | -5487.00 ILS | -10.48% |
| 2017 FY | - ILS | 4.77% |
| 2017 Q4 | -5447.00 ILS | 0.73% |
| 2017 Q1 | -4966.50 ILS | 18.27% |
| 2016 Q3 | -5038.00 ILS | -2.32% |
| 2016 Q2 | -4924.00 ILS | -12.75% |
| 2016 Q1 | -4367.00 ILS | -11.77% |
| 2016 FY | - ILS | -20.09% |
| 2016 Q4 | -6077.00 ILS | -20.62% |
| 2015 Q1 | -4124.00 ILS | 6.84% |
| 2015 Q4 | -3907.00 ILS | 11.49% |
| 2015 Q3 | -4414.00 ILS | -12.92% |
| 2015 Q2 | -3909.00 ILS | 5.21% |
| 2015 FY | - ILS | 13.95% |
| 2014 Q1 | -5715.00 ILS | 19.04% |
| 2014 FY | - ILS | 35.08% |
| 2014 Q4 | -4427.00 ILS | -11.79% |
| 2014 Q3 | -3960.00 ILS | 20.93% |
| 2014 Q2 | -5008.00 ILS | 12.37% |
| 2013 Q3 | -5775.00 ILS | -2.7% |
| 2013 FY | - ILS | -31.33% |
| 2013 Q1 | -5582.00 ILS | 99.91% |
| 2013 Q2 | -5623.00 ILS | -0.73% |
| 2013 Q4 | -7059.00 ILS | -22.23% |
| 2012 Q3 | -6.28 Million ILS | 0.0% |
| 2012 FY | - ILS | -107.25% |
| 2012 Q4 | -6.54 Million ILS | -4.12% |
| 2011 FY | - ILS | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|